1. Home
  2. JAMF vs HRMY Comparison

JAMF vs HRMY Comparison

Compare JAMF & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAMF
  • HRMY
  • Stock Information
  • Founded
  • JAMF 2002
  • HRMY 2017
  • Country
  • JAMF United States
  • HRMY United States
  • Employees
  • JAMF N/A
  • HRMY N/A
  • Industry
  • JAMF Computer Software: Prepackaged Software
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAMF Technology
  • HRMY Health Care
  • Exchange
  • JAMF Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • JAMF 1.4B
  • HRMY 1.6B
  • IPO Year
  • JAMF 2020
  • HRMY 2020
  • Fundamental
  • Price
  • JAMF $11.29
  • HRMY $34.09
  • Analyst Decision
  • JAMF Buy
  • HRMY Strong Buy
  • Analyst Count
  • JAMF 9
  • HRMY 8
  • Target Price
  • JAMF $19.89
  • HRMY $52.88
  • AVG Volume (30 Days)
  • JAMF 734.6K
  • HRMY 729.2K
  • Earning Date
  • JAMF 05-06-2025
  • HRMY 05-06-2025
  • Dividend Yield
  • JAMF N/A
  • HRMY N/A
  • EPS Growth
  • JAMF N/A
  • HRMY 13.13
  • EPS
  • JAMF N/A
  • HRMY 2.62
  • Revenue
  • JAMF $642,897,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • JAMF $9.86
  • HRMY $20.06
  • Revenue Next Year
  • JAMF $8.49
  • HRMY $18.40
  • P/E Ratio
  • JAMF N/A
  • HRMY $12.76
  • Revenue Growth
  • JAMF 10.75
  • HRMY 20.62
  • 52 Week Low
  • JAMF $9.95
  • HRMY $26.47
  • 52 Week High
  • JAMF $21.41
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • JAMF 45.49
  • HRMY 69.87
  • Support Level
  • JAMF $10.64
  • HRMY $29.82
  • Resistance Level
  • JAMF $12.67
  • HRMY $30.61
  • Average True Range (ATR)
  • JAMF 0.49
  • HRMY 1.15
  • MACD
  • JAMF 0.08
  • HRMY 0.71
  • Stochastic Oscillator
  • JAMF 40.77
  • HRMY 98.91

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: